BenchToBedside S8E3: FDA approved CAR T-cell therapy a paradigm shift in cancer treatment

CAR T Cells and T-Cell Therapies for Cancer

The CAR-T Revolution 3 Years After FDA Approval

[Acute Lymphoblastic Lymphoblastic Leukemia] FDA approval for sucessful cancer treatment using CAR-T

FDA Approval in AML, NDA Submitted in Myeloma, Clinical Hold on CAR T-cell Therapy Trials, and More

The FDA Approval of TIL Therapy and What it Means for Advanced Melanoma

FDA approved stem cell therapies

The First Solid Tumor T-Cell Therapy (Lifi) FDA Approval! The Target Price Upgrade to $31/share!

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

FDA Approvals in NHL and CINV, Priority Reviews in Melanoma and Breast Cancer, and More

The recent FDA approval of teclistamab for R/R multiple myeloma

FDA Approvals in CML, CTCL, CMV Infection, and Tumor Assay, and Clinical Holds Lifted

FDA Approves New Cancer Drug

Understanding US FDA Regulatory Responsibilities for Cell Therapy Companies

FDA approves cancer drug that could help thousands of people each year

FDA Clinical Investigator Training Course (CITC) 2022, Day 1 – Part 3

FDA Approval in Waldenstrom Macroglobulinemia, Priority Review and sNDA in Myeloma, and More

Cancer-fighting gene treatment approved by FDA

Drug Discovery: The Pathway to FDA Approval

Lecture 3 - FDA Drug Approval 101- Reading and Interpreting Cancer Trials Series